ALDX
NASD Aldeyra Therapeutics, Inc.$0.9058 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.9058, $0.0342 below the day’s high of $0.9400
- YTD change
- -82.51%
- vs 20-day SMA
- -25.42%
- vs 200-day SMA
- -64.77%
Price ranges
Price & Performance
-0.89 (-49.68%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 94.6% away from all-time highs of $16.7000
- ALDX is down 83% since the beginning of the year
- ALDX is down 83% over the past 12 months
- ALDX is down 32% over the past 1 month
- 5% of all ALDX investors are betting against ALDX
ALDX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -82.7%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0150
- Last 5 days
- -22.58%
- vs 8-day SMA
- -13.24%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
